These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 12632347)

  • 21. Results of treatment of fifty-six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: a report from The Intergroup Rhabdomyosarcoma Study-IV, 1991-1997.
    Raney RB; Stoner JA; Walterhouse DO; Andrassy RJ; Donaldson SS; Laurie F; Meyer WH; Qualman SJ; Crist WM;
    Pediatr Blood Cancer; 2004 Jun; 42(7):618-25. PubMed ID: 15127417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment and outcome of patients suffering from perineal/perianal rhabdomyosarcoma: results from the CWS trials--retrospective clinical study.
    Fuchs J; Dantonello TM; Blumenstock G; Kosztyla D; Klingebiel T; Leuschner I; Schuck A; Niggli FK; Koscielniak E; Seitz G
    Ann Surg; 2014 Jun; 259(6):1166-72. PubMed ID: 24045440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
    Stevens MC; Rey A; Bouvet N; Ellershaw C; Flamant F; Habrand JL; Marsden HB; Martelli H; Sanchez de Toledo J; Spicer RD; Spooner D; Terrier-Lacombe MJ; van Unnik A; Oberlin O
    J Clin Oncol; 2005 Apr; 23(12):2618-28. PubMed ID: 15728225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of outcome in children and adolescents with rhabdomyosarcoma of the trunk--the St Jude Children's Research Hospital experience.
    Chui CH; Billups CA; Pappo AS; Rao BN; Spunt SL
    J Pediatr Surg; 2005 Nov; 40(11):1691-5. PubMed ID: 16291153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group.
    Carli M; Ferrari A; Mattke A; Zanetti I; Casanova M; Bisogno G; Cecchetto G; Alaggio R; De Sio L; Koscielniak E; Sotti G; Treuner J
    J Clin Oncol; 2005 Nov; 23(33):8422-30. PubMed ID: 16293873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of rhabdomyosarcoma at the National Cancer Center Hospital].
    Beppu Y; Fukuma H; Chuma H; Ise T; Ohira M
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1603-13. PubMed ID: 3592704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089.
    Le Voyer TE; Sigurdson ER; Hanlon AL; Mayer RJ; Macdonald JS; Catalano PJ; Haller DG
    J Clin Oncol; 2003 Aug; 21(15):2912-9. PubMed ID: 12885809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rhabdomyosarcoma: therapeutic results and prospectives].
    Guglielmi M; Carli M
    Pediatr Med Chir; 1984; 6(2):179-84. PubMed ID: 6549408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics and the prognosis of childhood rhabdomyosarcoma in 60 patients treated at a single institute.
    Company F; Pedram M; Rezaei N
    Acta Med Iran; 2011; 49(4):219-24. PubMed ID: 21713731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Burke M; Anderson JR; Kao SC; Rodeberg D; Qualman SJ; Wolden SL; Meyer WH; Breitfeld PP;
    J Clin Oncol; 2007 Nov; 25(31):4909-13. PubMed ID: 17971587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarcoma of the prostate: a single institutional review.
    Janet NL; May AW; Akins RS
    Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A forty-year experience with anal carcinoma: changing trends and impact of multimodality therapy.
    Tolmos J; Vargas HI; Lim S; Stamos M
    Am Surg; 1997 Oct; 63(10):918-22. PubMed ID: 9322673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genital rhabdomyosarcoma: current management and review of the literature.
    Bell J; Averette H; Davis J; Toledano S
    Obstet Gynecol Surv; 1986 May; 41(5):257-63. PubMed ID: 3517719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
    Dantonello TM; Int-Veen C; Harms D; Leuschner I; Schmidt BF; Herbst M; Juergens H; Scheel-Walter HG; Bielack SS; Klingebiel T; Dickerhoff R; Kirsch S; Brecht I; Schmelzle R; Greulich M; Gadner H; Greiner J; Marky I; Treuner J; Koscielniak E
    J Clin Oncol; 2009 Mar; 27(9):1446-55. PubMed ID: 19224858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics and surgical treatment of perianal and perineal rhabdomyosarcoma: analysis of Japanese patients and comparison with IRSG reports.
    Okamura K; Yamamoto H; Ishimaru Y; Takayasu H; Otani Y; Yamagishi J; Takahashi A; Kuwano H; Nagashima K; Ikeda H
    Pediatr Surg Int; 2006 Feb; 22(2):129-34. PubMed ID: 16308704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes.
    Berger AC; Sigurdson ER; LeVoyer T; Hanlon A; Mayer RJ; Macdonald JS; Catalano PJ; Haller DG
    J Clin Oncol; 2005 Dec; 23(34):8706-12. PubMed ID: 16314630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.